Anavex Life Sciences
AVXL
#9984
Rank
ยฃ57.41 M
Marketcap
ยฃ0.62
Share price
-12.42%
Change (1 day)
-77.23%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -ยฃ9.63 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ30.3 Million, an increase over its 2024 earnings that were of -ยฃ39.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ9.63 Million-68.23%
2025 -ยฃ30.3 Million-22.43%
2024 -ยฃ39.06 Million14.77%
2023 -ยฃ34.03 Million-17.49%
2022 -ยฃ41.25 Million22.96%
2021 -ยฃ33.55 Million35.36%
2020 -ยฃ24.78 Million12.65%
2019 -ยฃ22 Million29.09%
2018 -ยฃ17.04 Million36.33%
2017 -ยฃ12.5 Million17.11%
2016 -ยฃ10.68 Million20.91%
2015 -ยฃ8.83 Million-6.29%
2014 -ยฃ9.42 Million337.28%
2013 -ยฃ2.16 Million
2008 -ยฃ3.99 Million106.01%
2007 -ยฃ1.94 Million8848.98%
2006 -ยฃ0.03 Million-79.99%
2005 -ยฃ0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ46.14 M-570.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
ยฃ84.02 M-956.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ6.35 Million-35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ0.27 Billion 2,638.61%๐Ÿ‡บ๐Ÿ‡ธ USA